0001213900-19-012782.txt : 20190715
0001213900-19-012782.hdr.sgml : 20190715
20190715201756
ACCESSION NUMBER: 0001213900-19-012782
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190711
FILED AS OF DATE: 20190715
DATE AS OF CHANGE: 20190715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Erony Joyce
CENTRAL INDEX KEY: 0001459212
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38468
FILM NUMBER: 19956074
MAIL ADDRESS:
STREET 1: C/O IGI LABORATORIES, INC.
STREET 2: 105 LINCOLN AVENUE
CITY: BUENA
STATE: NJ
ZIP: 08310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inspire Medical Systems, Inc.
CENTRAL INDEX KEY: 0001609550
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 261377674
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
BUSINESS PHONE: 763-957-5037
MAIL ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
4
1
ownership.xml
X0306
4
2019-07-11
0
0001609550
Inspire Medical Systems, Inc.
INSP
0001459212
Erony Joyce
C/O INSPIRE MEDICAL SYSTEMS, INC.
9700 63RD AVENUE NORTH, SUITE 200
MAPLE GROVE
MN
55369
1
0
0
0
Common Stock
2019-07-11
4
S
0
31519
66.7903
D
314332
I
See Footnote
Common Stock
2019-07-12
4
S
0
41075
66.6319
D
273257
I
See Footnote
Common Stock
2019-07-15
4
S
0
52866
68.5968
D
220391
I
See Footnote
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.57 to $67.51. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.24 to $67.75. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.16 to $69.29. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein.
/s/ Joyce Erony
2019-07-15